All terms in GO
| Label | Id | Description |
|---|---|---|
| regulation of protein localization to cell division site involved in cell separation after cytokinesis | GO_1905391 | [Any regulation of protein localization to cell division site that is involved in cell separation after cytokinesis.] |
| midbrain-hindbrain boundary structural organization | GO_0021552 | [The process that contributes to the act of creating the structural organization of the midbrain-hindbrain boundary structure. The midbrain-hindbrain domain of the embryonic brain is comprised of the mesencephalic vesicle and the first rhombencephalic vesicle at early somitogenesis stages. An organizing center at the boundary patterns the midbrain and hindbrain primordia of the neural plate.] |
| interleukin-27 receptor binding | GO_0045523 | [Interacting selectively and non-covalently with the interleukin-27 receptor.] |
| interleukin-24 production | GO_0032628 | [The appearance of interleukin-24 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.] |
| retromer complex binding | GO_1905394 | [Interacting selectively and non-covalently with a retromer complex.] |
| activated CD4-positive, alpha-beta T cell apoptotic process | GO_1905398 | [Any apoptotic process in an activated CD4-positive, alpha-beta T cell.] |
| T cell apoptotic process | GO_0070231 | [Any apoptotic process in a T cell, a type of lymphocyte whose defining characteristic is the expression of a T cell receptor complex.] |
| regulation of activated CD4-positive, alpha-beta T cell apoptotic process | GO_1905399 | [Any process that modulates the frequency, rate or extent of activated CD4-positive, alpha-beta T cell apoptotic process.] |
| regulation of T cell apoptotic process | GO_0070232 | [Any process that modulates the occurrence or rate of T cell death by apoptotic process.] |
| activated CD8-positive, alpha-beta T cell apoptotic process | GO_1905397 | [Any apoptotic process in an activated CD8-positive, alpha-beta T cell.] |
| interleukin-16 receptor binding | GO_0045514 | [Interacting selectively and non-covalently with the interleukin-16 receptor.] |
| interleukin-18 receptor binding | GO_0045515 | [Interacting selectively and non-covalently with the interleukin-18 receptor.] |
| interleukin-19 receptor binding | GO_0045516 | [Interacting selectively and non-covalently with the interleukin-19 receptor.] |
| interleukin-20 receptor binding | GO_0045517 | [Interacting selectively and non-covalently with the interleukin-20 receptor.] |
| interleukin-22 receptor binding | GO_0045518 | [Interacting selectively and non-covalently with the interleukin-22 receptor.] |
| interleukin-23 receptor binding | GO_0045519 | [Interacting selectively and non-covalently with the interleukin-23 receptor.] |
| interleukin-17 binding | GO_0019975 | [Interacting selectively and non-covalently with any member of the interleukin-17 family of cytokines.] |
| positive regulation of intralumenal vesicle formation | GO_1905367 | [Any process that activates or increases the frequency, rate or extent of intralumenal vesicle formation.] |
| positive regulation of endosome organization | GO_1904980 | [Any process that activates or increases the frequency, rate or extent of endosome organization.] |
| dehydrodolichyl diphosphate synthase activity | GO_0045547 | [Catalysis of the condensation of isopentenyl diphosphate and farnesyl diphosphate in the cis-configuration to form dehydrodolichyl diphosphate.] |